Re: Partner-smoking during pregnancy as predictor of mother's-quitting-rate

What is it about?

I, Dr. Saumya Pandey PH.D., feel exhilarated in providing a crisp snapshot of my successful research output published in reputed BJOG; my article highlights the emerging role of tobacco viz. cigarette smoking/active and/or passive in pregnant women of child-bearing age. Partners'/husbands' tobacco usage may adversely affect the outcome of a successful pregnancy in terms of biochemical pregnancy/human chorionic gonadotrophin positivity and clinical pregnancy/fetal cardiac activity/live birth. Good practice clinical research with written informed consent is warranted to provide public health-oriented significant and clinically meaningful data in reproductive research involving cohorts of specific genetic profiles. Tobacco is a known environmental carcinogen and therefore patient-friendly tobacco-cessation advice during pregnancy should be provided for cost-effective pregnancy management in women of differential socioeconomic strata and lifestyles.

Featured Image

Why is it important?

I, Dr. Saumya Pandey Ph.D., strongly advocate meaningful women-centric research with strict adherence to core tenets of bioethics including written informed consent of study participants. Tobacco-related research in reproductive medicine is warranted to provide cost-effective patient-friendly public health research models on a global platform involving pregnant women and their partners/husbands, and one to one tobacco-quitting/tobacco-cessation advice should be provided in a timely fashion so as to have successful pregnancy outcomes and reduce the possibility of miscarriages, stillbirths or embryonic developmental defects include aberrant notochord/cardiac developmental anomalies. Sample size, selection-bias free data sets are warranted to add to the growing knowledge of tobacco-mediated fertility/pregnancy research in diverse patient population pools worldwide.

Perspectives